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This study investigated the genetic characteristics of Toxoplasma gondii samples collected from 62
patients with toxoplasmosis in Sao Paulo State, Brazil. DNA samples were isolated from blood, cerebro-
spinal ﬂuid and amniotic ﬂuids of 25 patients with cerebral toxoplasmosis and AIDS, two patients with
acute toxoplasmosis, 12 patients with ocular toxoplasmosis, six newborns with congenital toxoplasmosis
and 17 pregnant women with acute infection. Diagnosis of toxoplasmosis was based in clinical, radiolog-
ical and laboratory features. Genotyping was performed using multilocus PCR–RFLP genetic markers
including SAG1, SAG2, 50- and 30-SAG2, alt.SAG2, SAG3, BTUB, GRA6, C22-8, c29-2, L358, PK1 and Apico.
Among the 62 clinical samples, 20 (32%) were successfully genotyped at eight or more genetic loci and
were grouped to three distinct genotypes. Eighteen samples belonged to ToxoDB Genotype #65 and
the other two samples were identiﬁed as ToxoDB Genotypes #6 and #71, respectively (http://tox-
odb.org/toxo/). Patients presenting Genotypes #6 and #71 had severe and atypical cerebral toxoplasmo-
sis, characterized by diffuse encephalitis without extensive brain lesions. These results indicate that T.
gondii Genotype #65 may have a high frequency in causing human toxoplasmosis in Sao Paulo State, Bra-
zil. This unusual ﬁnding highlights the need to investigate the possible association of parasite genotypes
with human toxoplasmosis.
 2011 Elsevier Inc. Open access under the Elsevier OA license. 1. Introduction
Toxoplasma gondii is a widespread protozoan parasite that in-
fects one third of the global human population (Dubey, 2008). Ge-
netic diversity of T. gondii strains has been an interesting and
important subject of research. In the past decades, the develop-
ment of highly sensitive and simple molecular methods facilitated
the detection, diagnosis and genotyping of this important parasitic
pathogen. With these molecular methods, it is possible to study the
potential correlation between parasite genotype and disease pat-
terns in infected patients, epidemiology, as well as population biol-
ogy of T. gondii (Dubey, 2008; Pereira-Chioccola et al., 2009).
High resolution of genotyping can be achieved using multilocus
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evier OA license. ods (Ajzenberg et al., 2004; Khan et al., 2007; Su et al., 2010). In
North America, Europe, and Africa, most isolates belong to the clo-
nal Type I, II, and III lineages, and there is no host boundary for dif-
ferent genotypes (Khan et al., 2007; Dardé et al., 1987; Sibley and
Boothroyd, 1992; Lehmann et al., 2004). In these regions, Type II
strains were predominant and commonly isolated from clinical
cases of toxoplasmosis. Among the three lineages the difference
at DNA sequence level is less than 1% on average, and it was sug-
gested that these three lineages were expanded globally in the past
10,000 years (Su et al., 2003). Studies conducted in Brazil and
French Guiana challenged the idea that T. gondii was clonal with
very small genetic variability. Genotyping results from these re-
gions showed a higher genetic variability with distinct genotypes
not identiﬁed in North America, Europe and Africa (Ajzenberg
et al., 2004; Fazaeli et al., 2000; Khan et al., 2006; Lindstrom
et al., 2006; Su et al., 2006; Demar et al., 2007; Dubey et al.,
2008; Ferreira et al., 2008; Pena et al., 2008; Vaudaux et al.,
2010). Analysis of 125 isolates from domestic animals in Brazil re-
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different hosts and locations, and they were considered to be the
common clonal lineages in Brazil (Pena et al., 2008).
Genetic analysis of T. gondii infection in human is of importance
to understand the epidemiology, transmission patterns and mech-
anisms of the disease. However, the difﬁculty of strain isolation in
human cases limits the data regarding T. gondii strain types. De-
spite that, genotyping studies were previously applied in human
congenital infection (Ajzenberg et al., 2002; Nowakowska et al.,
2006), human ocular infections (Vallochi et al., 2005), and AIDS pa-
tients (Ferreira et al., 2008; Fuentes et al., 2001; Gallego et al.,
2006), which provided preliminary information for further studies.
However, these early studies were limited to identify distinct iso-
lates, since fewer (Pereira-Chioccola et al., 2009; Ajzenberg et al.,
2004; Khan et al., 2007) genetic markers were used.
It is known the high prevalence of toxoplasmosis in the Brazil-
ian population with an elevated morbidity and mortality in ocular
and cerebral toxoplasmosis. Parasites had been detected in blood
and cerebrospinal ﬂuid (CSF) of these patients (Vidal et al., 2004;
Vidal et al., 2005; Colombo et al., 2005). Early studies using limited
number of genetic markers were inappropriate to distinguish the
most of the polymorphic Brazilian strains (Ferreira et al., 2008).
With the advent of multilocus PCR–RFLP such limitation can be
overcomed. This study was aimed to investigate the genetic char-
acteristics of the T. gondii strains isolated from patients with toxo-
plasmosis in Sao Paulo State by using recently developed typing
method.2. Materials and methods
2.1. Patients and clinical samples
This study was conducted using clinical samples from HIV-in-
fected patients, newborns, pregnant women and immunocompe-
tent patients admitted and treated at different public hospitals or
clinics located Sao Paulo State, Brazil. All samples received by Lab-
oratório de Parasitologia (Instituto Adolfo Lutz) and suspected of
toxoplasmosis were tested during routine diagnosis. Diagnosis of
toxoplasmosis was based in clinical, radiological and laboratory
features. The laboratorial methodologies included: (i) serological
exams as IgG and/or IgM antibodies to T. gondii detected by indi-
rect immunoﬂuorescence reaction (IF) (Colombo et al., 2005); (ii)
conventional PCR (cnPCR) and real-time PCR (qrtPCR) (Colombo
et al., 2005; Mesquita et al., 2010a). For patient with some immu-
nosuppression, CD4+ counts and serology for HIV were also inves-
tigated. During the period of January 2007–2010, positive results
for toxoplasmosis were shown in DNA samples extracted from
blood, CSF or amniotic ﬂuids of 25 patients with cerebral toxoplas-
mosis and AIDS, two patients with acute toxoplasmosis, 12 pa-
tients with ocular toxoplasmosis, six newborns with congenital
toxoplasmosis and 17 pregnant women with acute toxoplasmosis.
The institutional review boards of Ethics Committees of all in-
volved Institutions approved this study.2.2. T. gondii reference strains
The reference strains GTI, RH, PTG, ME49, CTG, VEG, TgCgCa1
(COUGAR), MAS, TgCatBr5 and TgCatBr64 were used as positive
control and as genotype indication in each genetic marker. Para-
sites were grown and maintained in VERO tissue cells. Tachyzoites
were harvested from culture supernatants, centrifuged and washed
twice at 2,000g for 10 min in phosphate-buffered saline, pH 7.2
(PBS). The parasite pellets were used for DNA extraction. RH strain
was used also for antigen preparation in IF. Tachyzoites were incu-
bated in 2% buffered formalin for 30 min at 37 C, washed twice inPBS at 1,000g for 10 min, and ﬁxed on glass slides (Colombo et al.,
2005).
2.3. Indirect immunoﬂuorescence reaction
The reactions were made in order to determine the presence or
absence of anti-T. gondii IgG and IgM antibodies and carried out as
previously described (Colombo et al., 2005). Samples were used in
serial dilutions and assayed in duplicate. The sera were diluted
from 1:4 to 1:4.096, and the cutoff was considered to be 1:16. Each
reaction contained two negative controls (PBS and one negative
serum) and one positive control (positive serum).
2.4. DNA extraction
DNA molecules were extracted from blood, amniotic ﬂuid and
tachyzoites using PureLink Genomic DNA Kits (Invitrogen) accord-
ing to the manufacturer’s instructions and described before (Mesq-
uita et al., 2010a). Blood samples were centrifuged and washed
with PBS at 2,500g for 10 min. The supernatants with plasma were
discarded. In order to lyse the erythrocytes, the packed cells were
mixed with three times the volume of a buffer containing 150 mM
ammonium chlorate, 1 mM potassium bicarbonate, 0.1 mM EDTA,
pH 7.3, incubated for 15 min at room temperature under mild
shaking and centrifuged for 10 min at 3,000 g. The blood pellets,
containing only nucleated cells were digested with proteinase K
(20 g/ml) in 50 mM Tris–HCl, 25 mM EDTA, pH 8.0, 2% sodium
dodecyl sulfate and incubated for 30 min at 56 C. DNA pellets
were dissolved in ultra pure water. DNA from CSF samples was ex-
tracted as described before (Vidal et al., 2004). Samples were cen-
trifuged for 10 min at 3,000g. After washing the packed cells twice
in PBS, whole cells were lysed by incubation at 100 C for 5 min in
50 ll of ultrapure water. DNA purity was determined by the ratio
of O. D. at 260 and 280 nm in a NanoDrop ND1000 (Thermo
Scientiﬁc).
2.5. Conventional PCR (cnPCR)
The reactions were carried out as described before (Mesquita
et al., 2010b). The DNA samples (or controls) and 25 pmol of each
primer were added to a kit purchased from Promega (Go Taq Green
Master Mix). The PCR mix (12.5 ll) was composed of 1 U of Taq
DNA polymerase, 10 mM Tris–HCl, pH 8.5; 50 mM KCl; 1.5 mM
MgCl2; and 200 mM of each of each dNTP. Each ampliﬁcation run
contained two negative controls (ultrapure water and a negative
DNA for toxoplasmosis) and one positive control (DNA extracted
from RH strain). The primer pair used was B22/B23, which ampli-
ﬁed a 115-bp sequence from a speciﬁc repetitive region of the B1
gene as target (Colombo et al., 2005; Burg et al., 1989). To control
the course of extraction and check for PCR inhibitors, all samples
were assayed using the primer pair b1/b2, which ampliﬁed a
140 bp fragment of the human b-globulin gene. After thermal cy-
cles, PCR products were electrophoresed in 2% agarose gel and
stained with ethidium bromide and visualized under UV
illumination.
2.6. Real time PCR (qrtPCR)
The ampliﬁcations were performed with an Applied Biosystems
7500 Real Time PCR System as described before (Mesquita et al.,
2010a). The clinical samples (or controls) were added to a reaction
mixture containing 10 ll of 2 TaqMan Universal PCR Master Mix
and 1 ll of the ‘‘Assay Mix’’ that included: (i) the forward primer,
18 lM; (ii) the reverse primer, 18 lM; and (iii) the TaqMan MGB
probe FAM dye-labeled, 5 lM. The primer set was B1Tg (TaqMan
probe, FAM dye-labeled and NFQ as quencher) that ampliﬁed an-
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contained two negative controls and one positive control, as used
in cnPCR.
2.7. PCR–RFLP for genotyping
The genotypes of T. gondii were performed using multilocus
PCR–RFLP, as previously described (Su et al., 2010, 2006). The ge-
netic markers were SAG1, SAG2 (50-and 30-SAG2, alt.SAG2) SAG3,
BTUB, GRA6, C22-8, c29-2, L358, PK1 and Apico. The set of reaction
included: (i) multiplex PCR; (ii) nested PCR; and (iii) ampliﬁed
product treatment with restriction enzymes. Each reaction set in-
cluded two negative controls (ultrapure water and a negative
DNA for toxoplasmosis); and at least ﬁve positive controls (refer-
ence strains).
2.8. Data analysis
Clinical and laboratory diagnosis were used to establish patient
status. The genotypes were compared, identiﬁed and matched to
those listed in ToxoDB at http://toxodb.org/toxo/.3. Results
All patients analyzed in this study had clinical and/or laboratory
diagnosis of toxoplasmosis. They had, at least, one positive PCR
(cnPCR or qrtPCR); and IgG or IgM antibodies anti-T. gondii, de-
tected by IF (except the patient Ct262 that had negative serology)
(Table 2).
DNA samples were isolated from blood, CSF and amniotic ﬂuids
of 25 patients with cerebral toxoplasmosis and AIDS, two patients
with acute toxoplasmosis, 12 patients with ocular toxoplasmosis,
six newborns with congenital toxoplasmosis and 17 pregnant wo-
men with acute toxoplasmosis. From these 62 clinical samples, 20
(32%) were successfully genotyped at eight or more genetic loci
(Fig. 1 and Table 1). Three genotypes were identiﬁed and matched
to those listed in ToxoDB. Eighteen of the 20 samples belonged to
ToxoDB Genotype #65 and the other two samples, Ct180 and
Ct534 belonged to Genotype #71 and Genotype #6, respectively.
Genotype #65 was previously identiﬁed from chicken and cat in
Brazil (isolates IDs: TgCkBr89 and TgCatBr82, both strains were vir-
ulent to mice) (Dubey et al., 2008; Pena et al., 2008). Genotype #71
was previously identiﬁed from chickens in Brazil (isolates IDs:
TgCkBr26 and TgCkBr69) (Dubey et al., 2008). Genotype #6 was
identiﬁed in different animals and is a major genotype in Brazil
(Type BrI). Strains belonging to this genotype are generally virulent
to mice (Pena et al., 2008).
The clinical and laboratorial details of the 20 patients, for which
T. gondii isolates were thoroughly genotyped, were shown in Ta-
ble 2. Among the 18 patients infected with Genotype #65 isolates,
acute toxoplasmosis was shown in three immunocompetent pa-
tients (At704, At358 and At176). One of whom was a woman that
developed the acute infection during the pregnancy but without
symptomatology (At176). One patient (CT262), negative for HIV
and without IgG and IgM to T. gondii, had acute infection with focal
cerebral toxoplasmosis. This patient had positive PCR and biopsy
results for T. gondii. Focal cerebral toxoplasmosis characterized
by multiple expansive brain lesions were observed in six patients
(Ct331, Ct384, Ct441, Ct527, Ct581, and Ct244). They were treated
with conventional anti-toxoplasmosis treatment (sulphadiazine,
pyrimetamine and folinic acid) and ﬁve of them were discharged
home. One patient (Ct581) had focal cerebral toxoplasmosis and
cytomegalovirus encephalitis and eventually died. Toxoplasmic
retinochoroiditis scars were shown in one patient with AIDS
(Ot539) and six immunocompetents (Ot692, Ot571, Ot607,Ot616, Ot622, and Ot508). Congenital toxoplasmosis was shown
in one infant with 6 months (Cot477).
Genotypes #71 and #6 were isolated from two patients with
diffuse cerebral toxoplasmosis (Ct180) and (Ct534), respectively.
Both patients had atypical cerebral toxoplasmosis, characterized
by diffuse encephalitis without visible expansive brain lesions in
images. Both cases had positive PCR for T. gondii in CSF and the pa-
tient (Ct180, Genotype #71) had brain histopathologic ﬁndings
consistent with toxoplasmosis, including the identiﬁcation of
stage-speciﬁc antigens of T. gondii. These two patients eventually
died, despite speciﬁc anti-toxoplasmosis therapy.
The 20 patients had active toxoplasmosis at different periods
(Table 2) and localities of São Paulo State. Thus, these data demon-
strated that there was no indication of any outbreak among these
patients.4. Discussion
Genotyping of T. gondii samples from clinical infections is chal-
lenging by the chronic nature of the infection, which is character-
ized by tissue cysts and an absence of circulating parasites. When
in active infection, however, small quantities of T. gondiimay enter
blood stream and therefore detectable. Multiplex PCR–RFLP made
it possible to genotype multiple loci using small among of DNA ex-
tracted from tissues such as CSF, amniotic ﬂuid, or blood. As the
sensitivity of this method is estimated to be 10-genome equivalent
per PCR (Su et al., 2010), only a small portion of clinical samples
can be genotyped. Among the 62 clinical DNA samples studied,
32% of them were typed.
The three genotypes determined in these clinical samples were
previously identiﬁed from farm or pet animal infections in Brazil,
indicating the importance of these animals serving as the reser-
voirs for human infection. Genotype #65 was previously identiﬁed
in chicken (TgCkBr89) from Rio de Janeiro (14) and cat (TgCatBr82)
from Sao Paulo State (Pena et al., 2008). This genotype differs at a
single locus (SAG1) from the major genotype BrIV in Brazil (Pena
et al., 2008). In our genotyping experiments, we did observed
ambiguity of alleles (allele I vs. u-1) at SAG1 locus, but due to
low DNA concentration, this problem could not be resolved with
conﬁdence. Therefore, there is possibility that this genotype is
identical to type BrIV, one of the major lineages in Brazil.
The frequency of Genotype #65 is unexpected, given the highly
diverse T. gondii population in Brazil. Dominance of one particular
T. gondii genotype in human toxoplasmosis has been reported pre-
viously. Analysis of 88 T. gondii isolates associated with toxoplas-
mosis with immunocompromised patients in France showed that
majority of these cases were caused by the clonal type II strains
(Ajzenberg et al., 2009). This reﬂects the high prevalence of type
II strains in Europe (Ajzenberg et al., 2002). Recent human toxo-
plasmosis outbreaks were also reported in South America (Demar
et al., 2007; Vaudaux et al., 2010). In each of these cases, oocysts
derived from a single T. gondii strain contaminating the environ-
ment are the likely source of infection. However, in current study,
there was no indication of outbreak in the patients studied, since
they had active toxoplasmosis at different periods and localities
of São Paulo State.
There are several possible explanations for the dominance of
Genotype #65 in these patients. First, PCR–RFLP has a biased sen-
sitivity towards Genotype #65. Second, PCR contamination falsely
ampliﬁed the same DNA sequence in a large number of samples.
Third, Genotype #65 is responsible for considerable part of human
infections in patients in Sao Paulo, Brazil. Fourth, Genotype #65 is
highly virulent to human and when activated, it can produce larger
amount of parasites than other genotypes, therefore becomes eas-
ier to be detected by PCR. Since the variation of DNA sequence
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Fig. 1. Representative gel images of RFLP genotyping (markers BTUB, c22-8 and L358). Sample IDs are at the top of the gel images, genotype results are at the bottom. GT1,
PTG, CTG, Ca1(TgCgCa1), MAS, Br5(TgCatBr5) and Br64(TgCatBr64) are reference strains (positive controls), Ctl is the negative control. MK is the DNA size marker with 903,
640, 411, 344, 240 and 220 base pair in fragment sizes, respectively.
Table 1
T. gondii genotypes determined in 20 human clinical samples.
Clinical sample codea Markers
SAG1 50 + 30 SAG2 SAG2 SAG3 BTUB GRA6 c22-8 c29-2 L358 PK1 Apico Genotype
At704 I I II III III III u-1 I I nd I ToxoDB #65b
At358 I I II III III III u-1 I I III I ToxoDB #65
At176 I I II III III III nd nd I III I ToxoDB #65
Ct262 I I II III III III u-1 I I III I ToxoDB #65
Ct384 I I II III III III u-1 I I nd I ToxoDB #65
Ct527 I I II III III III u-1 I I III I ToxoDB #65
Ct581 I I II III III III u-1 I I III I ToxoDB #65
Ct244 I I II III III III u-1 I I nd I ToxoDB #65
Ct331 I I II III III III u-1 I I III I ToxoDB #65
Ct441 I I II III III III nd I I nd nd ToxoDB #65
Ct180 I III III III III III II I III III I ToxoDB #71c
Ct534 I I I III I II u-1 I I I I ToxoDB #6d
Ot692 I I II III III III u-1 I I III I ToxoDB #65
Ot571 I I II III III III u-1 I I III I ToxoDB #65
Ot622 I I II III III III u-1 I I III I ToxoDB #65
Ot508 I I II III III III u-1 nd I nd nd ToxoDB #65
Ot539 I I II III III III u-1 I I III I ToxoDB #65
Ot607 I I II III III III u-1 I I III I ToxoDB #65
Ot616 I I II III III III u-1 I I III I ToxoDB #65
Cot477 I I II III III III u-1 I I III I ToxoDB #65
Nd: not determined.
a At (acute toxoplasmosis); Ct (cerebral toxoplasmosis); Cot (congenital toxoplasmosis); Ot (ocular toxoplasmosis) and patient number code.
b The listed Genotypes were previously identiﬁed in chicken (TgCkBr89) and cat (TgCatBr82) isolates (14, 16).
c The listed Genotypes were previously identiﬁed in chickens (TgCkBr26 and TgCkBr69) (14).
d The listed Genotypes were previously identiﬁed in cat (TgCatBr2) and chicken (TgCkBr144) isolates. This genotype is also known as type BrI (16). All from Brazil and
published in ToxoDB (http://toxodb.org/toxo/).
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likely the ﬁrst scenario will be true. Since direct typing of Toxo-
plasma in tissue samples is very sensitive to contamination, partic-
ularly true when DNA concentration of Toxoplasma is close to or
below detection threshold. It is possible that the high frequency
of Genotype #65 is the result of contamination. However, in ourexperiments, both positive and negative controls were included
to monitor contamination (Fig. 1), and questionable results were
re-tested to rule out contamination. To further minimize the inﬂu-
ence of potential contamination, we excluded all samples that can’t
be successfully typed for more than eight out of the 11 loci, assum-
ing these samples have low concentration and were not suitable
Table 2
Clinical and laboratory diagnostic results of the 20 patients with toxoplasmosis listed in Table 1.
Clinical
Sample
code/sample
collectiona
Age
(years)
Diagnosisb (clinical,
images and
laboratory data)
cnPCR qrtPCRc
(CT)
IF-IgGd IF-IgMd CD4+
lym
countse
HIV
(serology)
Brain histo-
pathology
for T. gondii
In
hospital
outcome
Toxoplas-
mosis
treatment
Genotype
At704-Bl-11/09 33 Acute toxoplasmosis Pos 22.7 1:256 1:16 nd Neg nd Alive Yes ToxoDB #65
At358-Bl-08/08 4 Acute toxoplasmosis Pos 31.9 1:1024 1:1024 nd Neg nd Alive Yes ToxoDB #65
At176-Af*-04/07 19 Acute toxoplasmosis
(pregnancy – asymptomatic)
Pos nd 1:16 Neg nd Neg nd Alive Yes ToxoDB #65
Ct262-Bl-10/07 29 Acute and focal cerebral
toxoplasmosis
Pos nd Neg Neg 498 Neg pos
(biopsy)
Alive Yes ToxoDB #65
Ct384-Bl-09/08 39 Focal cerebral toxoplasmosis Pos 36.3 1:4000 Neg 184 Pos nd Alive Yes ToxoDB #65
Ct527-Bl-05/09 36 Focal cerebral toxoplasmosis Pos 32 1:4000 Neg 89 Pos nd Alive Yes ToxoDB #65
Ct581-Bl-08/09 10 Focal cerebral toxoplasmosis
and cytomegalovirus
encephalitis
Pos 22.6 1:4000 Neg 2 Pos nd Death** Yes ToxoDB #65
Ct244-Bl-08/07 39 Focal cerebral toxoplasmosis Pos nd 1:256 Neg 56 Pos nd Alive Yes ToxoDB #65
Ct331-Bl-06/08 42 Focal cerebral toxoplasmosis Pos 27.3 1:256 Neg 9 Pos nd Alive Yes ToxoDB #65
Ct441-Bl-12/08 42 Focal cerebral toxoplasmosis Pos 29.9 1:16 Neg 17 Pos nd Alive Yes ToxoDB #65
Ct180-CSF-05/07 40 Diffuse cerebral toxoplasmosis Pos 31.0 1:4000 Neg 93 Pos pos (necropsy) Death Yes ToxoDB #71
Ct534-Bl/CSF-06/09 45 Diffuse cerebral toxoplasmosis Pos 32.9 1:4000 Neg 8 Pos nd Death Yes ToxoDB #6
Ot692-Bl-11/09 27 Ocular toxoplasmosis Pos 32 1:16 Neg nd Neg nd Alive Yes ToxoDB #65
Ot571-Bl-08/09 77 Ocular toxoplasmosis Pos 36 1:16 Neg nd Neg nd Alive Yes ToxoDB #65
Ot622-Bl-11/09 54 Ocular toxoplasmosis Pos 28.1 1:16 Neg nd Neg nd Alive Yes ToxoDB #65
Ot508-Bl-03/09 14 Ocular toxoplasmosis Pos 35 1:4000 Neg 299 Neg nd Alive Yes ToxoDB #65
Ot539-Bl-06/09 56 Ocular toxoplasmosis Pos 28 1:16 Neg nd Pos nd Alive Yes ToxoDB #65
Ot607-Bl-09/09 36 Ocular toxoplasmosis Pos 36.4 1:1024 Neg nd Neg nd Alive Yes ToxoDB #65
Ot616-Bl-09/09 60 Ocular toxoplasmosis Pos 25 1:16 Neg nd Neg nd Alive Yes ToxoDB #65
Cot477-Bl-01/09 0.6 Congenital toxoplasmosis Pos 18 1:16 Neg nd Ng nd Alive Yes ToxoDB #65
a At (acute toxoplasmosis); Ct (cerebral toxoplasmosis); Cot (congenital toxoplasmosis); Ot (ocular toxoplasmosis); patient number and clinical sample: Bl, blood;
Af, amniotic ﬂuid and CSF, cerebrospinal ﬂuid. Date (month/year) of the clinical sample collection.
b Diagnosis was deﬁned by clinical, images and laboratory data as described in Section 2.
c qrtPCR results were shown in CT (cycle threshold). Values below 40 were considerate positive (Mesquita et al., 2010a,b).
d Reagent serum and CSF were considered up to 1:16 and 1:4, respectively.
e Number of CD4+ T lymphocytes/ll of blood.
* IF were determined in serum sample.
** Cytomegalovirus encephalitis was concomitant to diagnosis of cerebral toxoplasmosis. nd, no determined; neg, negative; pos, positive.
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completely in these experiments, it is not likely the major explana-
tion to the genotyping results. The third and fourth scenarios are of
biological signiﬁcance. However, direct genotyping of clinical sam-
ples cannot distinguish the two possibilities. Therefore, isolate T.
gondii strains for further analysis is absolutely necessary.
The other genotypes identiﬁed were Genotype #71 which was
previously identiﬁed in chicken (TgCkBr26 and TgCkBr69) from
Rio de Janeiro (Dubey et al., 2008). The genotype #6 is the major
virulent lineage type BrI previously reported in Brazil (Ferreira
et al., 2008). It was also the cause of waterborne outbreak of toxo-
plasmosis in Santa Isabel in Brazil (Vaudaux et al., 2010). Both
Genotype #71 and #6 were isolated from patients with severe
and diffuse cerebral toxoplasmosis. Although scarce, there are
some prior reports about disease presentation of human toxoplas-
mosis and parasite genotypes, particularly related to non-clonal
genotypes from North America (Grigg et al., 2001), Europe (Bossi
and Bricaire, 2004; Delhaes et al., 2010), and Brazil (Khan et al.,
2006). In addition, a recent study showed that T. gondii causes
more severe ocular disease in congenitally infected children in Bra-
zil compared with Europe and suggest that marked differences
may be due to infection with more virulent genotypes of the para-
site that predominate in Brazil but are rarely found in Europe (Gil-
bert et al., 2008). However, the extent to which host genetics,
immune status, parasitic burden, parasitic genotype, and exposure
rate contribute to clinical disease is unknown.
This study showed that it is possible to directly genotype clini-
cal T. gondii infection in human patients using multilocus PCR–
RFLP method. The results of this study revealed an unusual high
frequency of Genotype #65. This can be explained by two possibil-
ities: (i) Genotype #65 is responsible for a large proportion of hu-man infections in Sao Paulo, Brazil; or (ii) Genotype #65 is highly
virulent to human and can lead to high parasite burden in tissues
than other genotypes, therefore can be preferentially detected by
PCR. This study highlighted the need to isolate T. gondii strains
from patients for further analysis and to evaluate potential associ-
ation of T. gondii Genotype #65 with toxoplasmosis in human
patients.
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